Related Experiment Videos
[Wearing-off phenomenon--neurological approach].
1Department of Neurology, Nishi-Ojiya National Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 9, 2000
Summary
Managing Parkinson's disease wearing-off involves strategic L-dopa timing and dosage. Continuous drug delivery methods also effectively control this common motor fluctuation, improving patient outcomes.
Area of Science:
- Neurology
- Pharmacology
Context:
- Parkinson's disease is a progressive neurodegenerative disorder.
- The wearing-off phenomenon is a common motor complication of levodopa therapy.
Purpose:
- To describe the mechanism of the wearing-off phenomenon in Parkinson's disease.
- To outline strategies for controlling wearing-off using anti-Parkinsonian medications.
Summary:
- Administering levodopa (L-dopa) before meals enhances absorption, and frequent dosing (4-5 times daily) helps manage wearing-off.
- Dopamine agonists and monoamine oxidase inhibitors can control and potentially prevent wearing-off.
- Continuous drug administration via intra-alimentary or subcutaneous routes offers a specific method for managing this phenomenon.
Impact:
- Optimizing medication timing and delivery can significantly improve motor control in Parkinson's patients.
- Early management of wearing-off is crucial for maintaining treatment efficacy and patient quality of life.